Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Impact of Fenebrutinib Treatment on MRI Outcomes and Cerebrospinal Fluid Penetrance in Multiple Sclerosis: Results from the Phase II FENopta Study

Author:Bar-Or, Amit   Dufek, Michal   Budincevic, Hrvoje   Drulovic, Jelena   Habek, Mario   Hua, Le H   Weber, Martin S.   Thomas, Piia   Napieralski, Julie   Clayton, David   Kuruvilla, Denison   Qi, Qi   Xu, Yan   Goodyear, Alexandra   Oh, Jiwon   

Session Name:S31: Multiple Sclerosis: Therapeutics and Clinical Decision Making  

Topic:Multiple Sclerosis  

Program Number:S31.004  

Author Institution:University of Pennsylvania, Philadelphia, PA  St. Anne’s University, Brno, Czech Republic  Sveti Duh University Hospital, Zagreb, Croatia  University Clinical Center of Serbia, Belgrade, Serbia  University Hospital Center Zagreb and University of Zagreb, School of Medicine, Zagreb, Croatia  Lou Ruvo Center for Brain Health, Las Vegas, NV  Institute of Neuropathology and Department of Neurology, University Medical Center, Göttingen, Germany  Genentech Inc., South San Francisco, CA  St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada  

Serum Glial Fibrillary Acidic Protein as a Predictive Marker for Developing Central Vein Sign Lesions in Radiologically Isolated Syndrome

Author:Martin, Sarah-Jane   Brand-Arzamendi, Koroboshka   Lim, Timothy   Lee, Lisa Eunyoung   Guenette, Melanie   Suthiphosuwan, Suradech   Bharatha, Aditya   Oh, Jiwon   Schneider, Raphael   

Session Name:P7: Multiple Sclerosis: Biomarkers, Immunology, and Basic Science  

Topic:Multiple Sclerosis  

Program Number:P7.002  

Author Institution:St. Michael's Hospital, Toronto, ON, Canada  

The Safety Profile of Fenebrutinib in Patients with Multiple Sclerosis Is Consistent with Those in Previously Studied Autoimmune Indications

Author:Oh, Jiwon   Raievska, Anastasiia   Sierzega, Malgorzata   Cerqueira, João   Riley, Claire S.   Caunt, Maresa   Ratchford, John N.   Goodyear, Alexandra   Vanevski, Konstantina   Sormani, Maria Pia   Giovannoni, Gavin   

Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2  

Topic:Multiple Sclerosis  

Program Number:P9.012  

Author Institution:St. Michael's Hospital, University of Toronto, Toronto, ON, Canada  F. Hoffmann-La Roche Ltd, Basel, Switzerland  University of Minho, Braga, Portugal  Columbia University Medical Center, New York, NY  Genentech Inc., South San Francisco, CA  University of Genoa, Genoa, Italy  Blizard University, Queen Mary University of London, London, United Kingdom  

Is There a Prodrome to NMOSD? An Investigation of Neurologic Symptoms Preceding the First NMOSD Attack

Author:Lee, Sydney   Marrie, Ruth-Ann   Fadda, Giulia   Lee, Liesly   Muccilli, Alexandra   Vyas, Manav   Konig, Andrea   Rotstein, Dalia   

Session Name:P11: Autoimmune Neurology: NMO, MOG, TM  

Topic:Autoimmune Neurology  

Program Number:P11.005  

Author Institution:Adult Neurology Program, University of Toronto, Toronto, ON, Canada  University of Manitoba, Winnipeg, MB, Canada  University of Ottawa, Ottawa, ON, Canada  Sunnybrook Health Sciences Centre, Toronto, ON, Canada  Saint Michael's Hospital - Multiple Sclerosis Clinic, Toronto, ON, Canada  MV VYAS MEDICINE PROFESSIONAL CORPORATION, TORONTO, ON, Canada  St. Michael's Hospital, Toronto, ON, Canada